Apollo Hospitals Enterprise Limited

rs,

IT A-'0110 ~OSPITALS The Secretary, Bombay Stock Exchange Ltd (BSE) Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 508869 ISIN INE437A01024 'G' Block The Secretary

68%

Health & Pharmacy Distribution 44 Owned + 5 Managed Hospitals 9,155 Owned & Managed Beds 68% Occupancy ` 57,391 / day ARPOB1 H1FY24: 65% H1FY24: ` 57,581 149,197 In-patients 22 Ambulator

65%

5 Managed Hospitals 9,155 Owned & Managed Beds 68% Occupancy ` 57,391 / day ARPOB1 H1FY24: 65% H1FY24: ` 57,581 149,197 In-patients 22 Ambulatory care & Birthing Centers 634 Beds 2,165 D

rs 634

ay ARPOB1 H1FY24: 65% H1FY24: ` 57,581 149,197 In-patients 22 Ambulatory care & Birthing Centers 634 Beds 2,165 Diagnostics Centers 327 Clinics 126 Dialysis Centers 142 Dental Centers 5,671 Out

rs 327

1 149,197 In-patients 22 Ambulatory care & Birthing Centers 634 Beds 2,165 Diagnostics Centers 327 Clinics 126 Dialysis Centers 142 Dental Centers 5,671 Outlets ~16.52% Private label / Generic

rs 142

y care & Birthing Centers 634 Beds 2,165 Diagnostics Centers 327 Clinics 126 Dialysis Centers 142 Dental Centers 5,671 Outlets ~16.52% Private label / Generic sales ~29 mm Registered users ~6,

rs 5,671

enters 634 Beds 2,165 Diagnostics Centers 327 Clinics 126 Dialysis Centers 142 Dental Centers 5,671 Outlets ~16.52% Private label / Generic sales ~29 mm Registered users ~6,200+ Doctors 1ARPOB is

16.52%

,165 Diagnostics Centers 327 Clinics 126 Dialysis Centers 142 Dental Centers 5,671 Outlets ~16.52% Private label / Generic sales ~29 mm Registered users ~6,200+ Doctors 1ARPOB is net of fees pai

rs 1

nters 5,671 Outlets ~16.52% Private label / Generic sales ~29 mm Registered users ~6,200+ Doctors 1ARPOB is net of fees paid to “fee for service doctors” and is netted off in the Reported Revenues.

12%

o) Growth YoY(%) EBITDA1 Margin (%) PAT (in ₹ Mio) Growth YoY(%) Healthcare Services 25,472 12% 6,345 11% 24.9% 3,136 14% o C h t l a e H Offline PD^ 17,143 14% 1,304 9% 7.6% Onl

11%

Y(%) EBITDA1 Margin (%) PAT (in ₹ Mio) Growth YoY(%) Healthcare Services 25,472 12% 6,345 11% 24.9% 3,136 14% o C h t l a e H Offline PD^ 17,143 14% 1,304 9% 7.6% Online PD^ & 24

24.9%

EBITDA1 Margin (%) PAT (in ₹ Mio) Growth YoY(%) Healthcare Services 25,472 12% 6,345 11% 24.9% 3,136 14% o C h t l a e H Offline PD^ 17,143 14% 1,304 9% 7.6% Online PD^ & 24|7 2,3

“This will be Apollo's second hospital in Kolkata and fifth in the eastern region, and Apollo further strengthens its position as the largest healthcare provider in the region with over 1800 beds across Kolkata, Bhubaneshwar and Guwahati.”

“o Expect to break-even in Q3’ FY24 pre-ESOP and post ESOP in Q4’ FY24”

“On track to achieve Rs 10,000 cr of revenues with 6% EBITDA in current fiscal year.”

Notes

2

Omnichannel Pharmacy

2

Regd. Office

1

General Office

1

Digital Operational Metrics

1

Offline segment

1

Healthco

1

General Office

"Ali Towers" Ill Floor, #55, Greams Road, Chennai - 600 006. Tel Telefax Email Website : www.apollohospitals.com : 044 - 2829 0956 I 3896 I 6681 : 044 - 2829 0956 : investor.relations@apollohospitals.com APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q2 FY24 01 Operational & Financial Snapshot 04 Diagnostics & Retail Health (AHLL) 02 Consolidated Financials 05 Digital Health & Pharmacy Distribution (Apollo HealthCo) 03 Healthcare Services 06 Annexure 2 Operational & Financial Snapshot 3 Q2FY24 Operational Snapshot Healthcare Services (Hospitals) Diagnostics & Retail Health Digital Health & Pharmacy Distribution 44 Owned + 5 Managed Hospitals 9,155 Owned & Managed Beds 68% Occupancy ` 57,391 / day ARPOB1 H1FY24: 65% H1FY24: ` 57,581 149,197 In-patients 22 Ambulatory care & Birthing Centers 634 Beds 2,165 Diagnostics Centers 327 Clinics 126 Dialysis Centers 142 Dental Centers 5,671 Outlets ~16.52% Private label / Generic sales ~29 mm Registered users ~6,200+ Doctors 1ARPOB is net of

Notes

(1) Tamilnadu region includes Chennai, Madurai, Karur, Karaikudi, Trichy & Nellore. (2) AP, Telangana Region includes Hyderabad, Karimnagar, Vizag old, Vizag new & Kakinada. (3) Karnataka region includes Bangalore, Mysore, Jayanagar & Malleswaram. (4) Eastern region includes Bhubaneswar, Bilaspur, Guwahati, Kolkata. (5) Western region includes Ahmedabad,Mumbai, Nashik. (6) Northern region includes Delhi, Lucknow and Indore (7) Revenues under the head “Total” have not been provided as Consolidated actual results will differ from total due to proportionate consolidation. (8) Outpatient volume represents New Registrations only. (9) Revenues under Ind AS have been grossed up for Fixed fee Doctors & considered separately as operating cost. This was earlier being netted off from Revenues under Indian GAAP. 13 ParticularsQ2 FY 23Q2 FY 24 yoy (%)Q2 FY 23Q2 FY 24 yoy (%)Q2 FY 23Q2 FY 24 yoy (%)No. of Operating beds1,7501,7718028611,1111,096Inpatient volume31,44532,7154.0%11,30014,02524.1%25,682

Notes

(1) Tamilnadu region includes Chennai, Madurai, Karur, Karaikudi, Trichy & Nellore. (2) AP, Telangana Region includes Hyderabad, Karimnagar, Vizag old, Vizag new & Kakinada. (3) Karnataka region includes Bangalore, Mysore, Jayanagar & Malleswaram. (4) Eastern region includes Bhubaneswar, Bilaspur, Guwahati, Kolkata. (5) Western region includes Ahmedabad,Mumbai, Nashik. (6) Northern region includes Delhi, Lucknow and Indore (7) Revenues under the head “Total” have not been provided as Consolidated actual results will differ from total due to proportionate consolidation. (8) Outpatient volume represents New Registrations only. (9) Revenues under Ind AS have been grossed up for Fixed fee Doctors & considered separately as operating cost. This was earlier being netted off from Revenues under Indian GAAP. 14 ParticularsH1 FY 23H1 FY 24 yoy (%)H1 FY 23H1 FY 24 yoy (%)H1 FY 23H1 FY 24 yoy (%)H1 FY 23H1 FY 24 yoy (%)No. of Operating beds7,8727,7652,1512,0491,2971,270761718Inpatient volume269,8

Omnichannel Pharmacy

o Omnichannel Pharmacy Business revenue of Rs 24,770 Mn in Q2’ FY24 compared to a revenue of Rs 20,497 Mn in Q2’ FY23 (growth of 21%). o o o Online grew 38% in Q2 FY24 vs Q2 FY23 ; Offline grew 19% in Q2 FY24 vs Q2 FY’23 Private label sales/ generic sales at 16.5%. On track to achieve Rs 10,000 cr of revenues with 6% EBITDA in current fiscal year.

Digital Operational Metrics

Platform GMV : Rs 7,256 Mn in Q2’FY24, growth of 147% over Q2’ FY23 and 16% growth over Q1’ FY24. Continuous Improvement in quantitative parameters in Q2’ FY24 vs Q2’ FY23; o Pharma AOV grew by 8% (Rs 956 vs Rs 885 a year back) o Transacting user base grew by 29% (12.8 lakh vs 9.9 lakh, a year back) * Excluding 24|7 operating Cost and ESOP Non-Cash Charge AHL- Revenue (in Mn) AHL- EBITDA ( Pre- ESOP) (in Mn) 2 0 , 0 0 0 1 9 , 5 0 0 1 9 , 0 0 0 1 8 , 5 0 0 1 8 , 0 0 0 1 7 , 5 0 0 1 7 , 0 0 0 1 6 , 5 0 0 1 6 , 0 0 0 1 5 , 5 0 0 1 5 , 0 0 0 17% 19,454 16,683 Q2'FY23 Q2'FY24 Q2'FY23 Q2'FY24

Offline segment

- - 5 0 0 -216 -36 83% o 18% YoY growth in transactions (6.9 cr Vs 5.8 cr year back). o Serving ~7.5 lac customers per day o Net Addition of 669 new stores (5,671 stores in Q2’ FY 24 vs 5,002 stores ending Q2’FY 23) 24 ` MioOffline Pharmacy Distribution Online Pharmacy Distribution & Apollo 247Total Health CoTotal Revenues17,1432,31219,454EBITDA*1,3042831,586margin (%) 7.60%12.2%8.2%24|7 Operating Cost-1,622-1,622ESOP Non Cash Charge-351-351EBITDA1,304-1,690-387margin (%) 7.6%--EBIT-512PBT-677PAT(Reported)-678Q2 FY 24Total Revenues16,0012,05318,054EBITDA*1,2502231,473margin (%) 7.81%10.88%8.16%24|7 Operating Cost-1,747-1,747ESOP Non Cash Charge-292-292EBITDA1,250-1,816-566margin (%) 7.8%--EBIT-687PBT-825PAT(Reported)-826Q1 FY 24 Apollo HealthCo Financials H1FY24